Skip to main content
. 2012 Apr 20;74(6):947–958. doi: 10.1111/j.1365-2125.2012.04302.x

Table 2A.

Efficacy endpoints in all patients receiving prophylactic LMWH or fondaparinux for thromboprophylaxis after major orthopaedic surgery (95% Blyth-Still-Casella confidence intervals)

LMWH n= 1495 Fondaparinux n= 1994
Efficacy endpoints % (n) 95% CI % (n) 95% CI P value
All VTE 4.15 (62) 3.19–5.23 5.62 (112) 4.67–6.68 0.047
 Proximal DVT 1.07 (16) 0.64–1.69 1.30 (26) 0.85–1.87 0.639
 PE 0.54 (8) 0.23–1.03 0.50 (10) 0.27–0.89 0.999
 Distal VTE 2.47 (37) 1.78–3.37 3.91 (78) 3.10–4.83 0.021